Cooley LLP advised NGM Biopharmaceuticals, while Davis Polk & Wardwell advised Jefferies, as sales agent in the offering. NGM Biopharmaceuticals (NASDAQ:NGM) announced its common stock for up to...
NGM Biopharmaceuticals’ $100 Million Common Stock Offering
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...